WASHINGTON - A press conference was interrupted on Thursday when a drug executive fainted in the Oval Office while President Donald Trump was announcing a deal with drugmakers to lower the cost of obesity drugs.

What we know:

On Friday, President Donald Trump was speaking to the press regarding a deal with Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

While giving comments, Dr. Oz jumped in as the drug executive of Novo Nordisk, Gordon Findlay, collapsed.

What we don't know:

His condition is currently unclear. FOX Local is reaching out to the White House for comment.

This is a developing story. Please check back for more updates. Politics U.S. Health Care Explainers News

See Full Page